Stock Wars Episode 3 – Genzyme & NYSE Rule 452

Had a blast talking about how the amended NYSE Rule 452 will benefit shareholders and keep corporate board members on their toes.  We also talked about Carl Icahn‘s campaign to take 4 of 9 board seats at Genzyme ($GENZ).

Check it…